An Update on Osteomyelitis Treatment in a Pycnodysostosis Patient

Osteomyelitis of the jaws in patients with pycnodysostosis: a systematic review

“… 12 In addition, flucloxacillin and ticarcilin-clavulanato were used in one case each, although the regimen was not specified. 21 , 22 In the lincosamide class, clindamycin 300 mg was the drug of choice, with a 4× daily regimen for 14 days in one case, 6 although in the other two articles the regimen was not specified; 14 , 22 in addition to lincomycin 500 mg for 10 days, used in one case. 23 …”

“… 17 Our results were consistent with the literature, with the mandible being the most affected site (n = 22). 2 , 5 , 6 , 11 , 12 , 13 , 14 , 15 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 27 , 28 , 29 , 30 …”

“…Oral manifestations include an obtuse mandibular angle, malocclusion, an ogival palate, and dental anomalies. 1 , 6 The abnormal bone metabolism increases the susceptibility of patients to develop osteomyelitis. In gnathic bones, local factors related to the development of osteomyelitis include the bone characteristics of the maxilla and mandible, continuous traumas, alveolar surgical procedures, and conditions that affect the teeth such as periapical and periodontal disease.…”

Updated Review of Traumatic Dislocation of the Mandibular Condyle Into the Middle Cranial Fossa

“…This study was performed in 2 phases according to a model proposed in the literature. [16][17][18] Two authors (J.L.G.C.M. and J.A.A.d.A.)…”

Metabolic Disorders in Patients with Chronic Osteomyelitis: Etiology and Pathogenesis

“…Most publications refer to dentistry and maxillofacial surgery but not to traumatology and/or orthopedics. Another search based on Mesh terms "Osteomyelitis" and "Metabolic disorders" (latest access time: December 08, 2019, 0:03 UTC +3) has provided 596 results, but most papers refer to other topics and problems: "combinations" of chronic osteomyelitis and diabetes mellitus [1,2], chronic osteomyelitis and bisphosphonate-induced necrosis of the jaw [3,4]; less papers refer to the problem of treating chronic osteomyelitis in patients with genetic, systemic, neuropathic, and oncological diseases [5][6][7][8]. In several papers, the accent is put on the clinical aspects of bone infection with particular pathogens only [9][10][11].…”